Algo version: 0.98b
Sihuan Pharmaceutical is listed at the HKSE Exchange
Sihuan Pharmaceutical [0460.HK]
HKSE Sector: Industry:Drug Manufacturers

Is Sihuan Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Sihuan Pharmaceutical pays dividends. Last time was Thursday 10th of October 2024 where the investors holding the stock on Friday 27th of September 2024 were paid HKD0.021 per share. Over the last 24 times between 2011 and 2024, Sihuan Pharmaceutical has paid HKD0.9521 with an average of HKD0.04 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Sihuan Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD1.380, you would have made a loss of HKD-0.830 per share or -60.14%

Yes, the average daily trading liquidity for Sihuan Pharmaceutical is HKD9.18 million. You should therefore be able to get in and out of your positions relatively fast.

Sihuan Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.16, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Sihuan Pharmaceutical to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.